Treatment for pancreatic cancer: current therapy and continued progress.
about
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsTargeting p110gamma in gastrointestinal cancers: attack on multiple frontsMucin-based targeted pancreatic cancer therapyRon knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi)Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerBayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.Extra-intestinal manifestations of familial adenomatous polyposisRecent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.Apoptosis induced by microwave radiation in pancreatic cancer JF305 cells.EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.Polyphenol-rich extract of Salvia chinensis exhibits anticancer activity in different cancer cell lines, and induces cell cycle arrest at the G₀/G₁-phase, apoptosis and loss of mitochondrial membrane potential in pancreatic cancer cells.The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2.Clinical significance of clusterin expression in pancreatic adenocarcinomaAberrant glycogen synthase kinase 3β in the development of pancreatic cancer.Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancersSystematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells.Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials.Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors.Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy.Transport properties of pancreatic cancer describe gemcitabine delivery and responseExpression of truncated bile salt-dependent lipase variant in pancreatic pre-neoplastic lesions.Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options.Drugs in preclinical and early-stage clinical development for pancreatic cancer.An autopsy study to clarify characteristics of local recurrence after extended pancreatectomy with intraoperative radiation therapy in patients with pancreatic cancer.Prognostic factors related with survival in patients with pancreatic adenocarcinomaThe surgical anatomy of the lymphatic system of the pancreas.Cytotoxicity of gemcitabine enhanced by polyphenolics from Aronia melanocarpa in pancreatic cancer cell line AsPC-1.Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells.Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency.EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials.Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.Distal Pancreatectomy with En Bloc Resection of the Celiac Axis with Preservation or Reconstruction of the Left Gastric Artery in Patients with Pancreatic Body Cancer.
P2860
Q26799046-1CEBDA6D-AAE4-4E13-A955-AFEB8C762778Q26823575-224ABEFE-968F-4FAA-9061-69487D520156Q26861761-61E06E83-908C-4FFC-914A-D30AA8FB8561Q28534954-6C4CFD6E-A241-4410-8CBC-0807F35646C2Q28729144-EA73B36A-9CF3-455B-AF3D-CF228ABDC71CQ30952198-C5BB030B-4B41-43FD-A646-971746BD64A9Q34297701-1EF3F2E0-3EEC-4569-B677-226EB9291136Q34593970-36E746EE-46CA-48BF-AA05-77D3CA1369D8Q35000796-79B16353-05CB-4CB4-887D-6B465306212BQ35140911-E88CF74F-6F00-4705-BF72-EED1583B77DAQ35234491-F0AA1B7E-1ABC-491B-90A1-23E10D2FB401Q35776154-429C0AD2-AF2C-4615-B45D-97B1B12BCE90Q36089689-AA40A1AE-4DC7-4E01-A2C5-0266107AD248Q36123027-D7669507-0B1A-469F-817B-8B806BFF24A5Q36217919-D8F76FEA-79AF-46AD-83C0-5607B449B1C5Q36450022-24843D88-4EC0-4775-A2AC-99C4F7090CACQ36545489-D75F5A8A-8181-46FC-9BB8-717AEA94ED7DQ36610277-BB590454-652B-4B96-B6F5-5F64C143DA45Q36613644-6093285A-8EAE-4D08-98EC-18D48846CD46Q36747372-EC98E2BF-1F48-4232-AAEB-D2F323DB7CC5Q36801789-D0D8695C-936C-4205-A871-2AE0A40C9F64Q37129787-7219FE91-E478-41CC-B0B2-C7570F9422DCQ37184771-14762138-AD72-40C0-B136-3FFA9B8DD0CAQ37284812-0A62FE67-E22E-4D65-A5A6-3BBE71B9F35EQ37467860-C7A148D8-6862-4777-9730-07A7E7255D1BQ37679971-6034B434-AE99-4832-8EC3-A07F1E6D7C3CQ37702308-89FF6D73-783E-40DE-9041-78ABB59B8F92Q37742975-CFE47424-CF73-4AF0-9724-1981A0E30279Q37973133-FB0AC7A8-8A1A-480A-AF4D-832642157959Q37989835-B4339487-44DD-40CB-86AA-468BFC1C51E4Q38242807-54BFE5CB-75B5-432F-B3BD-BFD52B2CD6D3Q38249137-D0F2B4FC-09F7-4CAA-880D-5E0C73954315Q38955438-229F247D-36C1-4A4C-BB1F-8FFBF5612C4CQ38971297-F4CA0D56-71FF-439C-B5FC-EB4F817F140EQ39022283-EA88DB25-1B96-401E-B7B3-40E9007F25F9Q39024706-B200A1E6-43E5-4656-BAB1-3F77E420ECAEQ39151780-2D65F375-11C8-48F5-BC21-94165183214FQ39233456-720186DE-EDF0-428D-8555-0BFC650288E2Q39589062-8997A654-E38A-4686-A64F-99E6DA7EE52FQ39751529-65AD3E14-521B-4EDF-AFF8-56FB8C5799FC
P2860
Treatment for pancreatic cancer: current therapy and continued progress.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment for pancreatic cancer: current therapy and continued progress.
@ast
Treatment for pancreatic cancer: current therapy and continued progress.
@en
type
label
Treatment for pancreatic cancer: current therapy and continued progress.
@ast
Treatment for pancreatic cancer: current therapy and continued progress.
@en
prefLabel
Treatment for pancreatic cancer: current therapy and continued progress.
@ast
Treatment for pancreatic cancer: current therapy and continued progress.
@en
P2093
P1433
P1476
Treatment for pancreatic cancer: current therapy and continued progress.
@en
P2093
A Craig Lockhart
Jordan D Berlin
Mace L Rothenberg
P304
P356
10.1053/J.GASTRO.2005.03.039
P407
P577
2005-05-01T00:00:00Z